Form 8-K - Current report:
SEC Accession No. 0001021771-24-000190
Filing Date
2024-11-07
Accepted
2024-11-06 17:55:43
Documents
17
Period of Report
2024-11-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL PRELIMINARY PHASE 2 DATA AND REVIEW OF THIRD QUARTER CONFERENCE CALL brt8k11624.htm   iXBRL 8-K 25617
5 PRESS RELEASE ex99_1.htm EX-99.1 1413
6 brtxpr_1.jpg GRAPHIC 1012468
7 brtxpr_2.jpg GRAPHIC 1253349
8 brtxpr_3.jpg GRAPHIC 312775
  Complete submission text file 0001021771-24-000190.txt   3712586

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA brtx-20241106.xsd EX-101.SCH 3883
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20241106_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20241106_pre.xml EX-101.PRE 16056
19 EXTRACTED XBRL INSTANCE DOCUMENT brt8k11624_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 241432463
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)